Infectious Disease Therapeutics Market To Reach $283.91 Billion By 2030

Infectious Disease Therapeutics Market Growth & Trends

The global infectious disease therapeutics market size is expected to reach USD 283.91 billion by 2030, registering a CAGR of 3.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing number of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and hepatitis cases globally.

Government and private organizations are investing heavily in the healthcare sector to prevent, diagnose, and treat infectious diseases; rising investments for development of new drugs to treat infectious diseases, and increasing number of initiatives for creating awareness about these conditions are expected to boost the market during the forecast period. Furthermore, increasing number of patent expirations and entry of generic drugs in the market are expected to increase the demand for infectious disease therapeutics due to their low prices.

In addition, availability of reimbursement for diagnosis & treatment of these infections and free distribution of drugs by manufacturers in regions with high incidence of these diseases are factors further expected to propel the market growth. However, low penetration rate of anti-infective and availability of large number of counterfeit drugs are expected to restraint the market growth during the forecast period.

North American market held the largest share in 2016. Presence of large number of manufacturers, favorable reimbursement scenario, and increasing healthcare expenditure are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. High prevalence of infectious diseases; improving economic conditions in Asian countries, rising government initiatives to increase the adoption of treatments for infectious diseases, and rising funding activities are factors that can be attributed for the highest growth rate of this region during the forecast period.

 Request a free sample copy or view report summary: Infectious Disease Therapeutics Market Report

Infectious Disease Therapeutics Market Report Highlights

• Viral infections dominated the market with a 42.58% share in 2024. The parasitic infections segment is the fastest-growing market, driven by increasing prevalence, rising drug resistance, and global health initiatives targeting malaria, leishmaniasis, and schistosomiasis.

• Vaccines dominated the anti-infective agents market with a 32.75% share in 2024, driven by rising disease prevalence, growing awareness, and strong government immunization programs. The antiparasitic drugs segment is experiencing significant growth due to the rising prevalence of malaria, leishmaniasis, and other parasitic infections.

• Hospital pharmacies dominated the market with a revenue share of 52.19% in 2024, driven by the rising number of hospitalizations globally.The other pharmacy segment is experiencing rapid growth due to the increasing adoption of online pharmacies, which enhance accessibility and convenience for infectious disease therapeutics.

• North America holds a leading position in the 2024 infectious disease therapeutics market, accounting for 38.09% of the global share. The infectious disease therapeutics market in Asia Pacific is expanding due to the rising prevalence of bacterial and viral infections and improving healthcare infrastructure.

Infectious Disease Therapeutics Market Segmentation

Grand View Research has segmented global infectious disease therapeutics market report based on infection, drug class, distribution channel, and region:

Infectious Disease Therapeutics Infection Outlook (Revenue, USD Million, 2018 - 2030)

• Bacterial Infections

• Viral Infections

  • Human Immunodeficiency Virus (HIV/AIDS)

  • Hepatitis (Hepatitis B, Hepatitis C)

  • Influenza

  • Others

• Fungal Infections

• Parasitic Infections

Infectious Disease Therapeutics Drug Class Outlook (Revenue, USD Million, 2018 - 2030)

• Antibacterials

• Antivirals

• Antifungals

• Antiparasitic Drugs

• Vaccines

• Others

Infectious Disease Therapeutics Distribution Channel Outlook (Revenue, USD Million, 2018- 2030)

• Hospital Pharmacies

• Retail Pharmacies

• Others

Infectious Disease Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • India

  • Japan

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Infectious Disease Therapeutics Market

• Pfizer Inc.

• AbbVie.

• Gilead Sciences, Inc.

• Bristol-Myers Squibb

• Merck & Co., Inc.

• Sandoz International GmbH

• B. Braun SE

• Xellia Pharmaceuticals

• Mankind Pharma

• Bayer AG

• AstraZeneca

• Boehringer Ingelheim International GmbH.

• Novartis AG

• F. Hoffmann-La Roche Ltd